EUVIMEDEUVIMED entdecken
Crossref

IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt

Rania A. Zayed, Zainab El-Saadany, Hanan Nour Raslan, Mohammed Ghareeb, Dalia Ibraheem, Marwa Rashed, Rania Kandil, Omnia Y. Abdeldayem

Meta Gene · 2020-12 · 26 · 100773

DOI: 10.1016/j.mgene.2020.100773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Meta Gene, 2020-12. Verfasst von Rania A. Zayed und 7 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-17 is a proinflammatory cytokine family produced by Th-17 cells and has been found to be implicated in the pathophysiology of many cancers including acute myeloid leukemia (AML). Since single nucleotide polymorphism (SNP) alters the genetic functions and cancer susceptibility, we studied SNPs in two members of IL-17 family, IL-17A (rs2275913; G-197A) and IL-17F (rs763780; A7488G) which are the most common loci associated with IL-17 activity and cancer risk, and correlated the results to AML susceptibility and response to therapy. The study included 200 participants; 100 de novo AML patients and 100 age and sex matched healthy control subjects. SNPs in IL-17A (rs2275913; G-197A) and IL-17F (rs763780; A7488G) were studied using restriction fragment length polymorphism polymerase chain reaction (PCR-RFLP). IL-17A homozygote mutation was more frequent in AML patients compared to control subjects (P = 0.034) and conferred 2.8 fold increased risk of AML (OR = 2.755 [95% CI: 1.078–7.042]). While IL-17F mutation showed no correlation with acute myeloid leukemia susceptibility. Also neither IL-17 A nor IL 17-F mutation showed significant correlation to therapy outcome. In conclusion, IL-17 A homozygote mutation may be associated with AML susceptibility.

Zitieren

APA

Zayed, R. A., El-Saadany, Z., Raslan, H. N., Ghareeb, M., Ibraheem, D., Rashed, M., Kandil, R., & Abdeldayem, O. Y. (2020). IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt. Meta Gene, 26, 100773. https://doi.org/10.1016/j.mgene.2020.100773

Vancouver

Zayed RA, El-Saadany Z, Raslan HN, Ghareeb M, Ibraheem D, Rashed M, et al. IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt. Meta Gene. 2020;26:100773. doi:10.1016/j.mgene.2020.100773

BibTeX
@article{Zayed2020,
  author = {Zayed, Rania A. and El-Saadany, Zainab and Raslan, Hanan Nour and Ghareeb, Mohammed and Ibraheem, Dalia and Rashed, Marwa and Kandil, Rania and Abdeldayem, Omnia Y.},
  title = {IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt},
  journal = {Meta Gene},
  year = {2020},
  volume = {26},
  pages = {100773},
  doi = {10.1016/j.mgene.2020.100773}
}
Kostenlos starten →